Literature DB >> 24196829

Dynamic tumor growth patterns in a novel murine model of colorectal cancer.

Terrah J Paul Olson1, Jamie N Hadac, Chelsie K Sievers, Alyssa A Leystra, Dustin A Deming, Christopher D Zahm, Dawn M Albrecht, Alice Nomura, Laura A Nettekoven, Lauren K Plesh, Linda Clipson, Ruth Sullivan, Michael A Newton, William R Schelman, Richard B Halberg.   

Abstract

Colorectal cancer often arises from adenomatous colonic polyps. Polyps can grow and progress to cancer, but may also remain static in size, regress, or resolve. Predicting which polyps progress and which remain benign is difficult. We developed a novel long-lived murine model of colorectal cancer with tumors that can be followed by colonoscopy. Our aim was to assess whether these tumors have similar growth patterns and histologic fates to human colorectal polyps to identify features to aid in risk stratification of colonic tumors. Long-lived Apc(Min/+) mice were treated with dextran sodium sulfate to promote colonic tumorigenesis. Tumor growth patterns were characterized by serial colonoscopy with biopsies obtained for immunohistochemistry and gene expression profiling. Tumors grew, remained static, regressed, or resolved over time with different relative frequencies. Newly developed tumors demonstrated higher rates of growth and resolution than more established tumors that tended to remain static in size. Colonic tumors were hyperplastic lesions (3%), adenomas (73%), intramucosal carcinomas (20%), or adenocarcinomas (3%). Interestingly, the level of β-catenin was higher in adenomas that became intratumoral carcinomas than those that failed to progress. In addition, differentially expressed genes between adenomas and intramucosal carcinomas were identified. This novel murine model of intestinal tumorigenesis develops colonic tumors that can be monitored by serial colonoscopy, mirror growth patterns seen in human colorectal polyps, and progress to colorectal cancer. Further characterization of cellular and molecular features is needed to determine which features can be used to risk-stratify polyps for progression to colorectal cancer and potentially guide prevention strategies. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24196829      PMCID: PMC4112462          DOI: 10.1158/1940-6207.CAPR-13-0163

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  40 in total

Review 1.  Mucins in cancer: protection and control of the cell surface.

Authors:  Michael A Hollingsworth; Benjamin J Swanson
Journal:  Nat Rev Cancer       Date:  2004-01       Impact factor: 60.716

2.  Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.

Authors:  Sidney J Winawer; Ann G Zauber; Robert H Fletcher; Jonathon S Stillman; Michael J O'brien; Bernard Levin; Robert A Smith; David A Lieberman; Randall W Burt; Theodore R Levin; John H Bond; Durado Brooks; Tim Byers; Neil Hyman; Lynne Kirk; Alan Thorson; Clifford Simmang; David Johnson; Douglas K Rex
Journal:  CA Cancer J Clin       Date:  2006 May-Jun       Impact factor: 508.702

3.  The role of mutant Apc in the development of dysplasia and cancer in the mouse model of dextran sulfate sodium-induced colitis.

Authors:  H S Cooper; L Everley; W C Chang; G Pfeiffer; B Lee; S Murthy; M L Clapper
Journal:  Gastroenterology       Date:  2001-12       Impact factor: 22.682

4.  Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors.

Authors:  Tim Reichling; Kathleen Heppner Goss; Daniel J Carson; Robert W Holdcraft; Cathy Ley-Ebert; Dave Witte; Bruce J Aronow; Joanna Groden
Journal:  Cancer Res       Date:  2005-01-01       Impact factor: 12.701

5.  Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years.

Authors:  B Hofstad; M H Vatn; S N Andersen; H S Huitfeldt; T Rognum; S Larsen; M Osnes
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

6.  Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand.

Authors:  Uri Ladabaum; Kenneth Song
Journal:  Gastroenterology       Date:  2005-10       Impact factor: 22.682

7.  ApcMin/+ mouse model of colon cancer: gene expression profiling in tumors.

Authors:  Daniel Leclerc; Liyuan Deng; Jacquetta Trasler; Rima Rozen
Journal:  J Cell Biochem       Date:  2004-12-15       Impact factor: 4.429

8.  Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?

Authors:  Laura C Seeff; Diane L Manninen; Fred B Dong; Sajal K Chattopadhyay; Marion R Nadel; Florence K L Tangka; Noelle-Angelique M Molinari
Journal:  Gastroenterology       Date:  2004-12       Impact factor: 22.682

9.  RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract.

Authors:  David Artis; Mei Lun Wang; Sue A Keilbaugh; Weimian He; Mario Brenes; Gary P Swain; Pamela A Knight; Deborah D Donaldson; Mitchell A Lazar; Hugh R P Miller; Gerhard A Schad; Phillip Scott; Gary D Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

Review 10.  Cancer genes and the pathways they control.

Authors:  Bert Vogelstein; Kenneth W Kinzler
Journal:  Nat Med       Date:  2004-08       Impact factor: 53.440

View more
  9 in total

1.  Colon Tumors with the Simultaneous Induction of Driver Mutations in APC, KRAS, and PIK3CA Still Progress through the Adenoma-to-carcinoma Sequence.

Authors:  Jamie N Hadac; Alyssa A Leystra; Terrah J Paul Olson; Molly E Maher; Susan N Payne; Alexander E Yueh; Alexander R Schwartz; Dawn M Albrecht; Linda Clipson; Cheri A Pasch; Kristina A Matkowskyj; Richard B Halberg; Dustin A Deming
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

Review 2.  New insights into the earliest stages of colorectal tumorigenesis.

Authors:  Chelsie K Sievers; William M Grady; Richard B Halberg; Perry J Pickhardt
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2017-05-26       Impact factor: 3.869

3.  Heterochromatin Protein 1 Binding Protein 3 Expression as a Candidate Marker of Intrinsic 5-Fluorouracil Resistance.

Authors:  Jamie N Hadac; Devon D Miller; Ian C Grimes; Linda Clipson; Michael A Newton; William R Schelman; Richard B Halberg
Journal:  Anticancer Res       Date:  2016-03       Impact factor: 2.480

4.  A molecular subtype of colorectal cancers initiates independently of epidermal growth factor receptor and has an accelerated growth rate mediated by IL10-dependent anergy.

Authors:  Carolina Mantilla-Rojas; Ming Yu; Erica S Rinella; Rachel M Lynch; Amie Perry; Jorge Jaimes-Alvarado; Kathryn R Anderson; Estefania Barba; Evann J Bourgeois; Kranti Konganti; David W Threadgill
Journal:  Oncogene       Date:  2021-03-25       Impact factor: 8.756

5.  Subclonal diversity arises early even in small colorectal tumours and contributes to differential growth fates.

Authors:  Chelsie K Sievers; Luli S Zou; Perry J Pickhardt; Kristina A Matkowskyj; Dawn M Albrecht; Linda Clipson; Jeffery W Bacher; B Dustin Pooler; Fouad J Moawad; Brooks D Cash; Mark Reichelderfer; Tien N Vo; Michael A Newton; Bret R Larget; Richard B Halberg
Journal:  Gut       Date:  2016-09-08       Impact factor: 23.059

Review 6.  Mouse models of colorectal cancer: Past, present and future perspectives.

Authors:  Florian Bürtin; Christina S Mullins; Michael Linnebacher
Journal:  World J Gastroenterol       Date:  2020-04-07       Impact factor: 5.742

7.  Epithelial-specific ERBB3 deletion results in a genetic background-dependent increase in intestinal and colon polyps that is mediated by EGFR.

Authors:  Carolina Mantilla Rojas; Michael P McGill; Anna C Salvador; David Bautz; David W Threadgill
Journal:  PLoS Genet       Date:  2021-11-29       Impact factor: 5.917

Review 8.  The utility of Apc-mutant rats in modeling human colon cancer.

Authors:  Amy A Irving; Kazuto Yoshimi; Marcia L Hart; Taybor Parker; Linda Clipson; Madeline R Ford; Takashi Kuramoto; William F Dove; James M Amos-Landgraf
Journal:  Dis Model Mech       Date:  2014-10-02       Impact factor: 5.758

9.  Experimental Model of Rectal Carcinogenesis Induced by N-Methyl-N-Nitrosoguanidine in Mice with Endoscopic Evaluation.

Authors:  Vanessa Foresto Machado; Rogerio Serafim Parra; Caio Abner Leite; Stefania Bovo Minto; Thiago Mattar Cunha; Fernando de Queiroz Cunha; Sergio Britto Garcia; Marley Ribeiro Feitosa; Jose Joaquim Ribeiro da Rocha; Omar Feres
Journal:  Int J Med Sci       Date:  2020-09-10       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.